Target intelligence / Profile preview

RNA, U6 small nuclear 310, pseudogene (RNU6-310P)

Target
RNU6-310P
Molecular classification
Other, Pseudogene, Small nuclear RNA (snRNA) pseudogene
01

Overview

RNA, U6 small nuclear 310, pseudogene (RNU6-310P) is a processed pseudogene of the U6 small nuclear RNA (snRNA) gene family. U6 snRNAs are essential components of the spliceosome, but pseudogenes such as RNU6-310P do **not encode functional RNAs or proteins** and are generally considered non-functional “genomic fossils.” Like other snRNA-derived pseudogenes, RNU6-310P may have arisen via LINE retrotransposition events and lacks the capacity for typical biological or pharmacological targeting. However, some pseudogenes can influence gene regulation through antisense, siRNA, or competing endogenous RNA effects, particularly in disease contexts such as cancer, but there is no specific evidence that RNU6-310P has such regulatory activity[2][4][5]. \n**RNU6-310P is not a therapeutic target** or functional receptor, enzyme, transporter, or drug target, but is rather a genomic pseudogene with no known direct functional or clinical significance. There is no evidence of approved drugs, biomarkers, or safety concerns related to this entry.\n\n**Note:** This entry is problematic for structured therapeutic target databases as it refers to a *pseudogene*, not an active molecular target.

Other names
RNU6-310PRNA, U6 Small Nuclear 310, Pseudogene
02

Biological functions

OtherMay play regulatory roles as some pseudogene RNAs can act as competing endogenous RNAs or siRNA sources
03

Disease associations

OtherSome pseudogenes have regulatory functions linked to cancer and other diseases, but no evidence specific to this pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 310, pseudogene (RNU6-310P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 310, pseudogene (RNU6-310P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call